NO942757L - 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-okso-kinolin-derivater - Google Patents

4-aryl-3-(heteroarylureido)-1,2-dihydro-2-okso-kinolin-derivater

Info

Publication number
NO942757L
NO942757L NO942757A NO942757A NO942757L NO 942757 L NO942757 L NO 942757L NO 942757 A NO942757 A NO 942757A NO 942757 A NO942757 A NO 942757A NO 942757 L NO942757 L NO 942757L
Authority
NO
Norway
Prior art keywords
formula
nitrogen
group
compounds
optionally substituted
Prior art date
Application number
NO942757A
Other languages
English (en)
Norwegian (no)
Other versions
NO942757D0 (no
Inventor
Ernest S Hamanaka
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO942757L publication Critical patent/NO942757L/no
Publication of NO942757D0 publication Critical patent/NO942757D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
NO942757A 1992-01-23 1994-07-22 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-okso-kinolin-derivater NO942757D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82463992A 1992-01-23 1992-01-23
PCT/US1992/010886 WO1993015058A1 (en) 1992-01-23 1992-12-21 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxo-quinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents

Publications (2)

Publication Number Publication Date
NO942757L true NO942757L (no) 1994-07-22
NO942757D0 NO942757D0 (no) 1994-07-22

Family

ID=25241935

Family Applications (1)

Application Number Title Priority Date Filing Date
NO942757A NO942757D0 (no) 1992-01-23 1994-07-22 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-okso-kinolin-derivater

Country Status (16)

Country Link
EP (1) EP0623112B1 (fi)
JP (1) JP2668163B2 (fi)
KR (1) KR950700284A (fi)
AT (1) ATE175196T1 (fi)
AU (1) AU3323393A (fi)
CA (1) CA2128093C (fi)
DE (1) DE69228069T2 (fi)
DK (1) DK0623112T3 (fi)
ES (1) ES2125325T3 (fi)
FI (2) FI930264A (fi)
HU (1) HUT63625A (fi)
IL (1) IL104420A0 (fi)
MX (1) MX9300361A (fi)
NO (1) NO942757D0 (fi)
WO (1) WO1993015058A1 (fi)
ZA (1) ZA93482B (fi)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6133326A (en) * 1994-08-31 2000-10-17 Pfizer Inc Compositions and methods for decreasing sebum production
WO1999043659A1 (fr) * 1998-02-25 1999-09-02 Sumitomo Pharmaceuticals Co., Ltd. Derives de pyridone et leur procede de fabrication
US6452008B2 (en) 1998-02-25 2002-09-17 Sumitomo Pharmaceuticals Company, Limited Pyridone derivatives and process for preparing the same
AU781563B2 (en) 2000-02-02 2005-06-02 Warner-Lambert Company Dual inhibitors of cholesterol ester and wax ester synthesis for sebaceous gland disorders
US8309562B2 (en) 2003-07-03 2012-11-13 Myrexis, Inc. Compounds and therapeutical use thereof
WO2006074147A2 (en) 2005-01-03 2006-07-13 Myriad Genetics, Inc. Nitrogen containing bicyclic compounds and therapeutical use thereof
FR2874922A1 (fr) * 2004-07-30 2006-03-10 Palumed Sa Molecules hybrides qa ou q est une aminoquinoleine et a est un residu antibiotique, leur synthese et leurs utilisations en tant qu'agent antibacterien
EP1771456A2 (fr) * 2004-07-30 2007-04-11 Palumed SA Molecules hybrides qa ou q est une aminoquinoleine et a est un residu antibiotique, leur synthese et leurs utilisations en tant qu'agent antibacterien
US8258145B2 (en) 2005-01-03 2012-09-04 Myrexis, Inc. Method of treating brain cancer
US11618751B1 (en) 2022-03-25 2023-04-04 Ventus Therapeutics U.S., Inc. Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 derivatives

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE892088L (en) * 1988-07-12 1990-01-12 William Henry Deryk Morris Quinoline derivatives, their production and use
WO1991004027A1 (en) * 1989-09-15 1991-04-04 Pfizer Inc. New n-aryl and n-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme a: cholesterol acyl transferase (acat)
TW205037B (fi) * 1989-10-06 1993-05-01 Takeda Pharm Industry Co Ltd
CA2075632C (en) * 1990-02-10 2001-10-16 Kanji Meguro Chromene derivatives, their production and use
BR9205939A (pt) * 1991-04-26 1994-09-27 Pfizer Derivados de 4-aril-3-(heteroalilureído)quinolina

Also Published As

Publication number Publication date
ES2125325T3 (es) 1999-03-01
WO1993015058A1 (en) 1993-08-05
JP2668163B2 (ja) 1997-10-27
AU3323393A (en) 1993-09-01
DK0623112T3 (da) 1999-08-30
EP0623112B1 (en) 1998-12-30
DE69228069T2 (de) 1999-05-20
CA2128093C (en) 1998-02-03
ATE175196T1 (de) 1999-01-15
ZA93482B (en) 1994-07-22
FI20010074A (fi) 2001-01-12
FI930264A0 (fi) 1993-01-22
IL104420A0 (en) 1993-05-13
KR950700284A (ko) 1995-01-16
NO942757D0 (no) 1994-07-22
EP0623112A1 (en) 1994-11-09
JPH07503712A (ja) 1995-04-20
FI930264A (fi) 1993-07-24
DE69228069D1 (de) 1999-02-11
CA2128093A1 (en) 1993-08-05
HUT63625A (en) 1993-09-28
HU9300197D0 (en) 1993-04-28
MX9300361A (es) 1994-06-30

Similar Documents

Publication Publication Date Title
DK1026147T3 (da) Forbindelser, der er anvendelige som mellemprodukter i fremstillingen af piperidinderivater
NO20013379D0 (no) 4-okso-1,4-dihydro-3-kinolinkarboksamider som antivirusmidler
FI943561A (fi) Uudet ainekoostumukset
DK254587D0 (da) Positionsspecifikke alkyleringsmidler
DE69428142D1 (de) Quinolin- oder Quinazolinderivate, deren Herstellung und Verwendung
NO942757D0 (no) 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-okso-kinolin-derivater
DE69314929D1 (de) Benzolderivate
ES2077697T3 (es) Derivados de 1-fenoxicarbonil-2-pirrolidinona y agentes nootropicos.